針刺治療偏頭痛急性期文獻質量評價_《中國循證醫學雜志》

作者：

楊春艷 , 劉慧林 , 張圓 ,  王麟鵬

首都醫科大學附屬北京中醫醫院針灸中心（北京 100010）;

關鍵詞：

針刺偏頭痛急性期/發作期文獻質量評價

DOI：

10.7507/1672-2531.20120059

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

目的　對針刺治療偏頭痛急性期的臨床隨機對照試驗研究進行文獻質量評價。
方法　以針刺、偏頭痛為檢索詞，檢索了Cochrane圖書館臨床對照試驗數據庫，PubMed、MEDLINE、EMbase等外文數據庫和CBM、CMCC、CNKI、VIP等中文數據庫。對納入研究的報告質量，包括研究設計的方法學質量、診斷與納入/排除標準、針刺/對照組干預措施、療效評價標準及觀察時間點、不良反應報告等方面進行評價。
結果　共納入23篇隨機對照試驗，2 645例患者，Jadad評分僅3篇屬高質量研究（≥ 4分）。文獻質量評價結果顯示，目前國內外關于針刺治療偏頭痛急性期的高質量臨床研究報道較少，國際公認的診斷標準及通用的評價方法尚未得到普遍應用，對照設置欠合理。
結論　從目前的臨床報道來看，針刺治療偏頭痛急性期有一定療效，但仍需相關證據支持。今后國內研究應嚴格遵循國際公認的偏頭痛診斷與療效評價標準，設置恰當的對照方法，進行高質量的研究。

引用本文： 楊春艷,劉慧林,張圓,王麟鵬. 針刺治療偏頭痛急性期文獻質量評價. 中國循證醫學雜志, 2012, 12(3): 365-370. doi: 10.7507/1672-2531.20120059 復制

1.	郭述蘇. 中國偏頭痛流行病學調查. 臨床神經病學雜志, 1991, 4(2): 65.
2.	Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 2007, 68(5): 343-349.
3.	Badia X, Magaz S, Gutierrez L, et al. The burden of migraine in Spain: beyond direct costs. Pharmacoeconomics, 2004, 22(9): 591-603.
4.	Wang SJ, Chung CS, Chankrachang S, et al. Migraine disability awareness campaign in Asia: migraine assessment for prophylaxis. Headache, 2008, 48(9): 1356-1365.
5.	Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol, 2010, 9(3): 285-298.
6.	Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology, 2004, 63(11): 2022-2027.
7.	Silberstein SD, McCrory DC. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache, 2003, 43(2): 144-166.
8.	Dodick D, Lipton RB, Martin V, et al. Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine. Headache, 2004, 44(5): 414-425.
9.	Endres HG, Diener HC, Molsberger A. Role of acupuncture in the treatment of migraine. Expert Rev OF Neurotherapeutics, 2007, 7(9): 1121-1134.
10.	張琰, 劉慧林, 王麟鵬. 針刺預防性治療偏頭痛的文獻質量評價. 中國循證醫學雜志, 2008, 8(6): 461-465.
11.	Headache classification committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia: an international journal of headache, 1988, 8(suppl7): 1-96.
12.	Headache classification subcommittee of the International Headache Society. The international classification of headache disorders : 2nd Edition. Cephalalgia: an international journal of headache, 2004, 24(Suppl1): 9-160.
13.	Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. The Cochrane Collaboration, 2006: 186-187.
14.	Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics, 1977, 33 (1): 159-174.
15.	Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ, 2001, 323(7303): 42-46.
16.	Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials, 1996, 17(1): 1-12.
17.	Melchart D, Thormaehlen J, HAGER S, et al. Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial. Journal of Internal Medicine, 2003, 253: 181–188.
18.	Li Y, Liang FR, Yang XG, et al. Acupuncture for Treating Acute Attacks of Migraine: A Randomized Controlled Trial. Headache, 2009, 49(6): 805-816.
19.	張舒雁, 馬澤云, 金國利. 鄰點透刺加纏針震顫法治療瘀血型偏頭痛急性發作療效觀察. 中華中醫藥學刊, 2007, 25(2): 401-403.
20.	鄧偉哲, 楊志欣. 深刺風池穴為主治療偏頭痛臨床觀察. 中國針灸, 2002, 22(10): 661-662.
21.	古英, 路瑜. 透刺為主治療偏頭痛的臨床觀察. 上海針灸雜志, 2008, 27(5): 24-25.
22.	劉波, 邱麗敏. 針刺“頭四關穴”治療偏頭痛的臨床研究. 遼寧中醫雜志, 2006, 33(11): 1484-1485.
23.	張月成, 宋麗華. 針刺耳門與西藥對照治療偏頭痛療效觀察. 中國針灸, 2002, 22(3): 159-160.
24.	孔慶愛, 高兵兵, 孟慶剛. 針刺療法治療偏頭痛98例分析. 中醫藥學刊, 2003, 21(12): 2164-2166.
25.	李冬梅, 賈寶輝. 針刺治療肝陽上亢型偏頭痛的臨床研究. 遼寧中醫雜志, 2009, 36(9): 1579-1581.
26.	寧俠, 張文. 針刺治療偏頭痛即刻療效的臨床觀察. 中國針灸, 2004: 11-12.
27.	張敏尚, 王秋景, 王山. 針刺治療偏頭痛3O例療效觀察. 四川中醫, 2005, 23(1): 91-92.
28.	周建偉, 李季, 李寧, 等. 電針太陽穴治療偏頭痛肝陽上亢證即時鎮痛效應研究. 中國針灸, 2007, 27(3): 159-163.
29.	陳宏偉, 楊國榮, 唐永春. 電針治療偏頭痛療效觀察. 上海針灸志, 2009, 28(6): 353-354.
30.	韓勵兵. 偏頭痛的針刺治療回顧. 中國針灸, 2005, 增刊: 18-19.
31.	王斌. 項叢刺合圍針治療偏頭痛. 上海針灸雜志, 2004, 23(4): 14-15.
32.	李志宏, 賀莉萍, 王靈, 等. 針刺手少陽經經穴為主治療偏頭痛32例臨床觀察. 湖南中醫雜志, 2009, 25(2): 11-12.
33.	黎俐, 哈依尼. 針刺四關穴治療偏頭痛36例. 中國醫學雜志, 2008, 6(9): 9-10.
34.	李麗霞, 王國明, 宋永強, 等. 針刺治療偏頭痛80例. 中國民間法, 2006, 14(5): 20-21.
35.	謝菊英, 劉伍立. 針刺治療偏頭痛及其對自主神經系統功能的影響. 中國針灸, 2003, 23(2): 77-79.
36.	謝菊英, 賀莉萍, 李志宏, 等. 針刺足厥陰經經穴治療偏頭痛及對顱內血流動力學的影響. 湘南學院學報(醫學版), 2008, 10(4): 24-27.
37.	謝菊英, 賀莉萍, 李志宏, 等. 針刺足少陽經經穴為主治療偏頭痛31例臨床觀察. 中醫藥導報, 2009, 15(4): 60-61.
38.	老錦雄, 賴新生. 透穴為主治療無先兆偏頭痛的臨床療效觀察. 中國針灸, 2002, 22(7): 448-450.
39.	周麗莎. 遵循標本根結理論針刺治療偏頭痛. 湖北中醫雜志, 2003, 25(3): 44-45.
40.	國家中醫藥管理局. 中醫病癥診斷療效標準. 南京大學出版社, 1994: 22-23.
41.	國家中醫藥管理局全國腦病急癥協作組. 頭風診斷與療效評定標準. 山東中醫藥大學學報, 1993, 16(3): 69.
42.	中華人民共和國衛生部. 中藥(新藥)臨床研究指導原則, 1995: 119-202.
43.	孫怡, 楊任民. 實用中西醫結合神經病學. 人民衛生出版社, 1999: 418-420, 426-427.
44.	孫增華, 楊玉金. 偏頭痛診斷、療效評定標準. 中風與神經病雜志, 1995, 12(2): 110.
45.	Sackett DL, Haynes RB, Guyatt GH, et al. Clinical epidemiology, a basic science for clinical medicine: 2nd ed. Boston : Little Brown Co Inc, 1991: 192-223.
46.	Altman DG, Schulz KF, Moher D, et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration. Ann Intern Med, 2001, 134: 663-694.
47.	Diener HC. Migraine: is acupuncture clinically viable for treating acute migraine? Nat Rev Neurol, 2009, 5(9): 469-470.
48.	Torgerson DJ, Roberts C. Randomisation methods: concealment. BMJ, 1999, 319(7206): 375 -376.
49.	Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of effects in controlled trials. JAMA, 1995, 273(5): 408-412.
50.	Eversa S, A´fra J, Frese A, et al. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. European Journal of Neurology, 2009, 16(9): 968-981.
51.	MacPherson H, White A, Cummings M, et al. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. Complement Ther Med, 2001, 9(4): 246-249.
52.	International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia, 2000, 20: 765-786.
53.	Suthisisang CC, Poolsup N, Suksomboon N, et al. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache, 2010, 50(5): 808-818.
54.	Chen LC, Ashcroft DM. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache, 2008, 48(2): 236-247.
55.	Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol, 2010, 9(4): 373-380.
56.	Tullo V, Allais G, Ferrari MD, et al. Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study. Neurol Sci, 2010, 31 Suppl 1: S51-S54.
57.	Spierings EL, Keywood C. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study. Pain Med, 2009, 10(4): 633-638.

1. 郭述蘇. 中國偏頭痛流行病學調查. 臨床神經病學雜志, 1991, 4(2): 65.
2. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 2007, 68(5): 343-349.
3. Badia X, Magaz S, Gutierrez L, et al. The burden of migraine in Spain: beyond direct costs. Pharmacoeconomics, 2004, 22(9): 591-603.
4. Wang SJ, Chung CS, Chankrachang S, et al. Migraine disability awareness campaign in Asia: migraine assessment for prophylaxis. Headache, 2008, 48(9): 1356-1365.
5. Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol, 2010, 9(3): 285-298.
6. Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology, 2004, 63(11): 2022-2027.
7. Silberstein SD, McCrory DC. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache, 2003, 43(2): 144-166.
8. Dodick D, Lipton RB, Martin V, et al. Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine. Headache, 2004, 44(5): 414-425.
9. Endres HG, Diener HC, Molsberger A. Role of acupuncture in the treatment of migraine. Expert Rev OF Neurotherapeutics, 2007, 7(9): 1121-1134.
10. 張琰, 劉慧林, 王麟鵬. 針刺預防性治療偏頭痛的文獻質量評價. 中國循證醫學雜志, 2008, 8(6): 461-465.
11. Headache classification committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia: an international journal of headache, 1988, 8(suppl7): 1-96.
12. Headache classification subcommittee of the International Headache Society. The international classification of headache disorders : 2nd Edition. Cephalalgia: an international journal of headache, 2004, 24(Suppl1): 9-160.
13. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. The Cochrane Collaboration, 2006: 186-187.
14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics, 1977, 33 (1): 159-174.
15. Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ, 2001, 323(7303): 42-46.
16. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials, 1996, 17(1): 1-12.
17. Melchart D, Thormaehlen J, HAGER S, et al. Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial. Journal of Internal Medicine, 2003, 253: 181–188.
18. Li Y, Liang FR, Yang XG, et al. Acupuncture for Treating Acute Attacks of Migraine: A Randomized Controlled Trial. Headache, 2009, 49(6): 805-816.
19. 張舒雁, 馬澤云, 金國利. 鄰點透刺加纏針震顫法治療瘀血型偏頭痛急性發作療效觀察. 中華中醫藥學刊, 2007, 25(2): 401-403.
20. 鄧偉哲, 楊志欣. 深刺風池穴為主治療偏頭痛臨床觀察. 中國針灸, 2002, 22(10): 661-662.
21. 古英, 路瑜. 透刺為主治療偏頭痛的臨床觀察. 上海針灸雜志, 2008, 27(5): 24-25.
22. 劉波, 邱麗敏. 針刺“頭四關穴”治療偏頭痛的臨床研究. 遼寧中醫雜志, 2006, 33(11): 1484-1485.
23. 張月成, 宋麗華. 針刺耳門與西藥對照治療偏頭痛療效觀察. 中國針灸, 2002, 22(3): 159-160.
24. 孔慶愛, 高兵兵, 孟慶剛. 針刺療法治療偏頭痛98例分析. 中醫藥學刊, 2003, 21(12): 2164-2166.
25. 李冬梅, 賈寶輝. 針刺治療肝陽上亢型偏頭痛的臨床研究. 遼寧中醫雜志, 2009, 36(9): 1579-1581.
26. 寧俠, 張文. 針刺治療偏頭痛即刻療效的臨床觀察. 中國針灸, 2004: 11-12.
27. 張敏尚, 王秋景, 王山. 針刺治療偏頭痛3O例療效觀察. 四川中醫, 2005, 23(1): 91-92.
28. 周建偉, 李季, 李寧, 等. 電針太陽穴治療偏頭痛肝陽上亢證即時鎮痛效應研究. 中國針灸, 2007, 27(3): 159-163.
29. 陳宏偉, 楊國榮, 唐永春. 電針治療偏頭痛療效觀察. 上海針灸志, 2009, 28(6): 353-354.
30. 韓勵兵. 偏頭痛的針刺治療回顧. 中國針灸, 2005, 增刊: 18-19.
31. 王斌. 項叢刺合圍針治療偏頭痛. 上海針灸雜志, 2004, 23(4): 14-15.
32. 李志宏, 賀莉萍, 王靈, 等. 針刺手少陽經經穴為主治療偏頭痛32例臨床觀察. 湖南中醫雜志, 2009, 25(2): 11-12.
33. 黎俐, 哈依尼. 針刺四關穴治療偏頭痛36例. 中國醫學雜志, 2008, 6(9): 9-10.
34. 李麗霞, 王國明, 宋永強, 等. 針刺治療偏頭痛80例. 中國民間法, 2006, 14(5): 20-21.
35. 謝菊英, 劉伍立. 針刺治療偏頭痛及其對自主神經系統功能的影響. 中國針灸, 2003, 23(2): 77-79.
36. 謝菊英, 賀莉萍, 李志宏, 等. 針刺足厥陰經經穴治療偏頭痛及對顱內血流動力學的影響. 湘南學院學報(醫學版), 2008, 10(4): 24-27.
37. 謝菊英, 賀莉萍, 李志宏, 等. 針刺足少陽經經穴為主治療偏頭痛31例臨床觀察. 中醫藥導報, 2009, 15(4): 60-61.
38. 老錦雄, 賴新生. 透穴為主治療無先兆偏頭痛的臨床療效觀察. 中國針灸, 2002, 22(7): 448-450.
39. 周麗莎. 遵循標本根結理論針刺治療偏頭痛. 湖北中醫雜志, 2003, 25(3): 44-45.
40. 國家中醫藥管理局. 中醫病癥診斷療效標準. 南京大學出版社, 1994: 22-23.
41. 國家中醫藥管理局全國腦病急癥協作組. 頭風診斷與療效評定標準. 山東中醫藥大學學報, 1993, 16(3): 69.
42. 中華人民共和國衛生部. 中藥(新藥)臨床研究指導原則, 1995: 119-202.
43. 孫怡, 楊任民. 實用中西醫結合神經病學. 人民衛生出版社, 1999: 418-420, 426-427.
44. 孫增華, 楊玉金. 偏頭痛診斷、療效評定標準. 中風與神經病雜志, 1995, 12(2): 110.
45. Sackett DL, Haynes RB, Guyatt GH, et al. Clinical epidemiology, a basic science for clinical medicine: 2nd ed. Boston : Little Brown Co Inc, 1991: 192-223.
46. Altman DG, Schulz KF, Moher D, et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration. Ann Intern Med, 2001, 134: 663-694.
47. Diener HC. Migraine: is acupuncture clinically viable for treating acute migraine? Nat Rev Neurol, 2009, 5(9): 469-470.
48. Torgerson DJ, Roberts C. Randomisation methods: concealment. BMJ, 1999, 319(7206): 375 -376.
49. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of effects in controlled trials. JAMA, 1995, 273(5): 408-412.
50. Eversa S, A´fra J, Frese A, et al. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. European Journal of Neurology, 2009, 16(9): 968-981.
51. MacPherson H, White A, Cummings M, et al. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. Complement Ther Med, 2001, 9(4): 246-249.
52. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia, 2000, 20: 765-786.
53. Suthisisang CC, Poolsup N, Suksomboon N, et al. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache, 2010, 50(5): 808-818.
54. Chen LC, Ashcroft DM. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache, 2008, 48(2): 236-247.
55. Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol, 2010, 9(4): 373-380.
56. Tullo V, Allais G, Ferrari MD, et al. Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study. Neurol Sci, 2010, 31 Suppl 1: S51-S54.
57. Spierings EL, Keywood C. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study. Pain Med, 2009, 10(4): 633-638.

上一篇
一例乙肝相關性腎炎伴腎功能衰竭患者的循證治療

《中國循證醫學雜志》

針刺治療偏頭痛急性期文獻質量評價

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

上一篇

Format

Content

《中國循證醫學雜志》

針刺治療偏頭痛急性期文獻質量評價

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

上一篇

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料